{"pmid":32347323,"title":"Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation.","text":["Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation.","Intensive Care Med","Leisman, Daniel E","Deutschman, Clifford S","Legrand, Matthieu","32347323"],"journal":"Intensive Care Med","authors":["Leisman, Daniel E","Deutschman, Clifford S","Legrand, Matthieu"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32347323","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1007/s00134-020-06059-6","topics":["Treatment","Mechanism"],"weight":1,"_version_":1665441658327531520,"score":8.599203,"similar":[{"pmid":32293083,"title":"Pulmonary thrombosis in 2019-nCoV pneumonia?","text":["Pulmonary thrombosis in 2019-nCoV pneumonia?","J Thromb Haemost","Marongiu, Francesco","Grandone, Elvira","Barcellona, Doris","32293083"],"journal":"J Thromb Haemost","authors":["Marongiu, Francesco","Grandone, Elvira","Barcellona, Doris"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32293083","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jth.14818","keywords":["2019 ncov","ards","dic","heparin","pulmonary thrombosis"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1665420446560944128,"score":75.25537},{"pmid":32346093,"title":"The trinity of COVID-19: immunity, inflammation and intervention.","text":["The trinity of COVID-19: immunity, inflammation and intervention.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into the virology of SARS-CoV-2, understanding the fundamental physiological and immunological processes underlying the clinical manifestations of COVID-19 is vital for the identification and rational design of effective therapies. Here, we provide an overview of the pathophysiology of SARS-CoV-2 infection. We describe the interaction of SARS-CoV-2 with the immune system and the subsequent contribution of dysfunctional immune responses to disease progression. From nascent reports describing SARS-CoV-2, we make inferences on the basis of the parallel pathophysiological and immunological features of the other human coronaviruses targeting the lower respiratory tract - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Finally, we highlight the implications of these approaches for potential therapeutic interventions that target viral infection and/or immunoregulation.","Nat Rev Immunol","Tay, Matthew Zirui","Poh, Chek Meng","Renia, Laurent","MacAry, Paul A","Ng, Lisa F P","32346093"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into the virology of SARS-CoV-2, understanding the fundamental physiological and immunological processes underlying the clinical manifestations of COVID-19 is vital for the identification and rational design of effective therapies. Here, we provide an overview of the pathophysiology of SARS-CoV-2 infection. We describe the interaction of SARS-CoV-2 with the immune system and the subsequent contribution of dysfunctional immune responses to disease progression. From nascent reports describing SARS-CoV-2, we make inferences on the basis of the parallel pathophysiological and immunological features of the other human coronaviruses targeting the lower respiratory tract - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Finally, we highlight the implications of these approaches for potential therapeutic interventions that target viral infection and/or immunoregulation."],"journal":"Nat Rev Immunol","authors":["Tay, Matthew Zirui","Poh, Chek Meng","Renia, Laurent","MacAry, Paul A","Ng, Lisa F P"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32346093","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1038/s41577-020-0311-8","topics":["Treatment","Mechanism"],"weight":1,"_version_":1665441658219528192,"score":71.810234},{"pmid":32286863,"title":"COVID-19, Arrhythmic Risk and Inflammation: Mind the Gap!","text":["COVID-19, Arrhythmic Risk and Inflammation: Mind the Gap!","Circulation","Lazzerini, Pietro Enea","Boutjdir, Mohamed","Capecchi, Pier Leopoldo","32286863"],"journal":"Circulation","authors":["Lazzerini, Pietro Enea","Boutjdir, Mohamed","Capecchi, Pier Leopoldo"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32286863","week":"202016|Apr 13 - Apr 19","doi":"10.1161/CIRCULATIONAHA.120.047293","source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"_version_":1664636391603044352,"score":69.51446},{"pmid":32312790,"title":"Faecal calprotectin indicates intestinal inflammation in COVID-19.","text":["Faecal calprotectin indicates intestinal inflammation in COVID-19.","Gut","Effenberger, Maria","Grabherr, Felix","Mayr, Lisa","Schwaerzler, Julian","Nairz, Manfred","Seifert, Markus","Hilbe, Richard","Seiwald, Stefanie","Scholl-Buergi, Sabine","Fritsche, Gernot","Bellmann-Weiler, Rosa","Weiss, Gunter","Muller, Thomas","Adolph, Timon Erik","Tilg, Herbert","32312790"],"journal":"Gut","authors":["Effenberger, Maria","Grabherr, Felix","Mayr, Lisa","Schwaerzler, Julian","Nairz, Manfred","Seifert, Markus","Hilbe, Richard","Seiwald, Stefanie","Scholl-Buergi, Sabine","Fritsche, Gernot","Bellmann-Weiler, Rosa","Weiss, Gunter","Muller, Thomas","Adolph, Timon Erik","Tilg, Herbert"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312790","week":"202017|Apr 20 - Apr 26","doi":"10.1136/gutjnl-2020-321388","keywords":["gut inflammation","infectious diarrhoea"],"source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"_version_":1664714520078057473,"score":69.51446},{"pmid":32317217,"title":"Role of thymopoiesis and inflamm-aging in COVID-19 phenotype.","text":["Role of thymopoiesis and inflamm-aging in COVID-19 phenotype.","Pediatr Neonatol","Scarpa, Raffaele","Costa, Luisa","Del Puente, Antonio","Caso, Francesco","32317217"],"journal":"Pediatr Neonatol","authors":["Scarpa, Raffaele","Costa, Luisa","Del Puente, Antonio","Caso, Francesco"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32317217","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.pedneo.2020.04.001","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1664815087739731968,"score":69.51446}]}